Related Experiment Video
Updated: Jun 30, 2026

In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells
Published on: September 28, 2017
The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response
Aaron E Hoffman1, Tongzhang Zheng, Yue Ba
1Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520, USA.
Abstract:
Apart from regulating sleep and wakefulness, the circadian system may play an important role in other biological processes, including pathways involved in tumorigenesis. Two genetic association studies recently conducted by our lab have shown that a missense mutation in neuronal PAS domain protein 2 (NPAS2), a core circadian gene and transcriptional regulator, is significantly associated with risk of breast cancer and non-Hodgkin's lymphoma. Our current functional analyses provide the first in vitro evidence further demonstrating that cells with RNA interference-mediated depletion of NPAS2 fail to exhibit the expected cell cycle delay in response to mutagen treatment. DNA repair capacity, as measured by the comet assay, is also impaired. Moreover, a pathway-based PCR expression array of genes important for DNA damage signaling showed that knockdown of NPAS2 significantly represses the expression of several cell cycle and DNA repair genes. Thus, NPAS2 may play a role in tumorigenesis by affecting expression of cancer-related genes and could be considered a novel tumor suppressor.
Insights
Neuronal PAS domain protein 2 (NPAS2), a circadian gene, is linked to cancer risk. NPAS2 depletion impairs cell cycle and DNA repair, suggesting it acts as a tumor suppressor.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The circadian system regulates sleep-wake cycles and influences various biological processes.
- Tumorigenesis pathways may be modulated by circadian gene function.
- Genetic studies linked mutations in neuronal PAS domain protein 2 (NPAS2) to increased breast cancer and non-Hodgkin's lymphoma risk.
Purpose of the Study:
- To investigate the functional role of NPAS2 in cellular responses to DNA damage.
- To explore the potential of NPAS2 as a tumor suppressor.
Main Methods:
- RNA interference (RNAi) to deplete NPAS2 in cells.
- Mutagen treatment to assess cell cycle delay.
- Comet assay to measure DNA repair capacity.
- Pathway-based PCR expression array to analyze gene expression.
Main Results:
- NPAS2-depleted cells failed to delay cell cycle progression after mutagen exposure.
- DNA repair capacity was significantly impaired in NPAS2-depleted cells.
- Knockdown of NPAS2 repressed the expression of key cell cycle and DNA repair genes.
Conclusions:
- NPAS2 plays a critical role in maintaining genomic stability by regulating cell cycle and DNA repair.
- NPAS2 influences the expression of cancer-related genes.
- NPAS2 is a potential novel tumor suppressor.
Related Concept Videos
Circadian Rhythms and Gene Regulation
Circadian Rhythms and Gene Regulation
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
